Where does 20/20 GeneSystems Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 20/20 GeneSystems Inc. ranks #38,485 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 20/20 GeneSystems Inc. hold?

20/20 GeneSystems Inc. holds 6 US utility patents granted between 2017 and 2024, spanning 6 technology areas.

What is 20/20 GeneSystems Inc.'s Innovation Score?

20/20 GeneSystems Inc. has an Innovation Score of 45.4 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 20/20 GeneSystems Inc. focus on?

20/20 GeneSystems Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 4 patents, ranking #3,181 of 7,863 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is 20/20 GeneSystems Inc.'s patent grant rate increasing or decreasing?

20/20 GeneSystems Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 20/20 GeneSystems Inc.'s patents?

20/20 GeneSystems Inc.'s patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 20/20 GeneSystems Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

20/20 GeneSystems Inc.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 20/20 ranks #38,485 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#38,485
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.4/100): 16.7
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38485 · US Corporation #38,485 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #38,485/49,997
PHOTO-FINISH 1964 Ears
CPC-NARROW G01N · 6 areas
INNOV-PAR 45.4/100
CLAIMS-RICH 16.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1964 Ears, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 20/20’s 45.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (15%) Velocity 20.0 pts (44%) Breadth 8.7 pts (19%) Claim depth 10.0 pts (22%)

Qualcomm Incorporated · highest

85
20/20 GeneSystems · this assignee

45
Blackmore Sensors &… · near

45
Gmems Tech Shenzhen · near

45
Microban Products · near

45
National Steel Car · near

45
3D Lighting… · lowest

7

What this shows 20/20's Innovation Score is 45.4/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 20/20?

Each dot is one of 20/20’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 20/20’s own 16.7 claims/patent is at or below the 18.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

20/20 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 20/20's grants concentrate

20/20 GeneSystems Inc. is a focused PatentsView assignee: 6 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2017. By volume, 20/20 sits between 1964 Ears, LLC and 2mee Ltd.

20/20's three-year grant acceleration

20/20 GeneSystems Inc. shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

1964 Ears

6
1997 Irrevocable…

6
19labs

6
2 HH

6
2028631 Ontario

6
2360216 Ontario

6
2breathe

6
2mee

6
20/20 Genesystems ◀

6

What this shows 20/20 holds 6 patents at rank #38,486, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 20/20

By rank, the assignees closest to #38,486 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in 20/20's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for 20/20, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), 20/20 ranks #3,181 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Gmems Tech Shenzhen Limited 45 National Steel Car Limited 45 Blackmore Sensors & Analytics, LLC. 45 Microban Products Company 45

20/20's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

20/20 GeneSystems Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	16.7%
2018	1	16.7%
2020	1	16.7%
2023	2	33.3%
2024	1	16.7%

Which technologies does 20/20 GeneSystems Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

20/20 GeneSystems Inc.'s patent record in context - here's where to go next.

20/20 GeneSystems Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 66.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #38,485 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 20/20 GeneSystems Inc. against 1964 Ears, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.